Marketplace / Healthtech / Pre-Seed
ALPFA Medical
“Transforming BPH Ablation with Pulsed Field Ablation technology.”
Overview
ALPFA Medical is a medical device company developing the ALPFA GRAIL system, a platform designed for the treatment of Benign Prostatic Hyperplasia (BPH). The company utilizes Pulsed Field Ablation (PFA) technology to provide a minimally invasive, non-thermal approach to prostate tissue ablation.
Traction
as reported by the founderCurrently in clinical study phase with the ALPFA GRAIL system.
Traditional BPH treatments often involve thermal energy, which carries a higher risk of complications and damage to surrounding structures like nerves and blood vessels.
The company targets the urology market, specifically addressing the large population of men suffering from symptomatic benign prostatic hyperplasia (BPH). They aim to provide a minimally invasive alternative to existing medical procedures for the 14+ million men actively managed for the condition in the US.
The ALPFA GRAIL system uses precisely controlled pulsed electric fields to selectively target and break down prostate cells while preserving surrounding anatomical structures.
Company updates
No updates posted yet.
Follow this company
Get an email when ALPFA Medical posts an update. No account needed — one click to unsubscribe.
Achievements
ALPFA Medical
Deck · financials · founder contact